Rachel Gibson

Rachel Gibson serves as Head of the School of Allied Health Science and Practice at the University of Adelaide, where she leads groundbreaking research in supportive cancer care and gut microbiome studies. A prolific researcher with over 120 journal articles, six book chapters, and 75 conference abstracts, she co-heads the Cancer Treatment Toxicities Group at Adelaide Medical School. Her research focuses on the toxic effects of chemotherapy on gut microbiome and the development of intestinal mucositis in cancer patients. Her contributions to the field earned her MASCC's 2019 Distinguished Service Award, the organization's highest honor. Previously serving as Professor and Dean: Academic in the Division of Health Sciences at University of South Australia, she has demonstrated excellence in both research and academic leadership. Her work spans pathology, molecular biology, microbiology, and immunology, while maintaining active involvement in developing clinical practice guidelines for mucositis management in cancer therapy. Beyond research, she is recognized as a skilled communicator and mentor, contributing significantly to global supportive care knowledge and practice.